ACTOnco+
Commercial- Indications
- Cancer
Company intelligence / Profile preview
ACT Genomics
Taipei City, Taiwanactgenomics.com ↗
- Ownership
- Private
- Employees
- ~104
- Development stage
- Commercial
01
Overview
ACT Genomics provides commercialized next-generation sequencing–based diagnostic assays and bioinformatics services to support precision oncology. Their products have received regulatory clearances including the first US FDA 510(k) clearance in Asia for a product of this type. They serve over 200 hospitals/clinics with more than twenty biopharma/research collaborations. The company’s solutions enable treatment selection, relapse/drug resistance monitoring, risk assessment, and immunotherapy evaluation across all solid cancers.
- Therapeutic areas
- Oncology
- Modalities
- Diagnostic test (NGS-based)Bioinformatics analysis platformCompanion diagnostics (CDx)Immuno-oncology profiling assay
- Industry
- Molecular Diagnostics
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Cerba Research (CerbACT Asia JV)Canon Medical System Corporation (Japan JV acquisition)multiple undisclosed biopharma partners (>20 collaborations)
Beyond the preview
Go deeper on ACT Genomics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ACT Genomics.